Physical Therapy

Global Physical Therapy Software Market Research Report 2024: Employment Trends Catalyzing Growth, Technological Innovations - Long-term Forecast to 2028 and 2033 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, April 9, 2024
Software, Technology, Health, Physical Therapy, Employment, PC, Growth, Prevalence, Therapy, EMR, Patient, Fracture, Bureau, Hospital, Health information management, Osteoporosis, Artificial intelligence, Movement

The "Physical Therapy Software Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Physical Therapy Software Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.
  • The global physical therapy software market is undergoing a significant expansion, with projections indicating a rise from $24.56 billion in 2023 to an impressive $34.87 billion by 2028, representing a steady CAGR of 7.3%.
  • A projected growth in the employment of physical therapists is forecast to have a commensurate effect on the demand for physical therapy software.
  • The consistent evolution of the physical therapy software market is indicative of a growing recognition of the critical role such technologies play in modern healthcare.

iHealthScreen Inc. is Awarded a US Patent on Glaucoma Detection, Which Is Based on AI and Color Fundus Imaging

Retrieved on: 
Tuesday, April 9, 2024
Physical Therapy, Technology, Managed Care, Health, Optical, Health Technology, Medical Devices, Photography, Software, Artificial Intelligence, Telemedicine, Virtual Medicine, Research, Diagnosis, Glaucoma, CE, Patient, Hospital, ARVO, IPredict, Paratriathlon, TGA, AMD, Diabetic retinopathy

The early screening and detection of glaucoma can potentially help prevent the progression to severe glaucoma and save millions of people from blindness.

Key Points: 
  • The early screening and detection of glaucoma can potentially help prevent the progression to severe glaucoma and save millions of people from blindness.
  • The entire test which includes color retinal imaging and the automated AI-based glaucoma report generation can easily and reliably be completed within 5 minutes.
  • Glaucoma detection offers an overall accuracy of 94.3% for identifying an individual with glaucoma.
  • iPredict’s glaucoma detection model can be used as follows:
    iPredict-glaucoma report will produce which will indicate referable (i.e., early to severe glaucoma) or non-referable glaucoma (not glaucoma).

Spineology® Appoints new Member to Leadership Team; Spine Veteran Emory Rooney joins as Executive Vice President of Sales

Retrieved on: 
Thursday, April 4, 2024
Medical Devices, Health, Hospitals, Surgery, Physical Therapy, Biotechnology, Freedom, University, Growth, Medicine, Learning, Central Florida, Inc., Area, Patient, Medical device, IDE, Surgeon, ATEC, Spine, Pain

Spineology Inc. ("Spineology" or the "Company"), the leader in ultra-minimally invasive spine surgery, announced today the addition of Emory Rooney as Executive Vice President, Sales.

Key Points: 
  • Spineology Inc. ("Spineology" or the "Company"), the leader in ultra-minimally invasive spine surgery, announced today the addition of Emory Rooney as Executive Vice President, Sales.
  • Rooney comes to Spineology with extensive spine sales experience, having served in Medical Device fields related to spinal implants and navigation for nearly 20 years.
  • “The addition of Emory adds even further conviction about our clear opportunity for growth at Spineology,” said Brian Snider, Chief Executive Officer at Spineology.
  • Prior to joining Spineology, Mr. Rooney spent nearly six years with Alphatec Spine (Nasdaq: ATEC), where he served as the Vice President of Sales, East.

Acadia Healthcare Appoints Dr. Stephanie Eken as Chief Medical Officer

Retrieved on: 
Thursday, April 4, 2024
Mental Health, Health, Hospitals, Physical Therapy, Managed Care, General Health, Psychiatry, Patient, Mental health, Child, University, Adolescence, Pediatrics, Acadia Healthcare, Safety, Multimedia, Medical device

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced the appointment of Dr. Stephanie Eken as the Company’s new chief medical officer.

Key Points: 
  • Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced the appointment of Dr. Stephanie Eken as the Company’s new chief medical officer.
  • View the full release here: https://www.businesswire.com/news/home/20240404108920/en/
    Acadia Healthcare Appoints Dr. Stephanie Eken as Chief Medical Officer (Photo: Business Wire)
    “Acadia is thrilled to welcome Dr. Eken as our new chief medical officer,” said Chris Hunter, Chief Executive Officer of Acadia Healthcare.
  • “This is an exciting time to join Acadia Healthcare,” said Dr. Eken.
  • Dr. Genovese departs Acadia after 10 years with the Company, seven of those as its chief medical officer.

ProMed Pharma Acquires SpineThera Manufacturing Capabilities and an Option to License Intellectual Property

Retrieved on: 
Wednesday, April 3, 2024
Chemicals, Plastics, Electronic Design Automation, Manufacturing, Technology, Pharmaceutical, Physical Therapy, Medical Devices, Clinical Trials, Other Technology, Biotechnology, Science, Veterinary, Other Science, Research, Health, Engineering, CDMO, Business, Patient, CNS, ProMED-mail, CGMP, Animal Health, Sale, Business development, CMC, Acquisition, Clinical trial, Fine chemical

ProMed Pharma also obtained an option to license SpineThera’s microsphere intellectual property with the potential to sub-license to ProMed Pharma’s customers.

Key Points: 
  • ProMed Pharma also obtained an option to license SpineThera’s microsphere intellectual property with the potential to sub-license to ProMed Pharma’s customers.
  • Importantly, SpineThera is maintaining exclusive ownership of intellectual property that enables SX600.
  • With this transaction, our manufacturing team joins a highly capable CDMO, ProMed Pharma, a company we have worked with closely for many years.
  • SpineThera becomes a customer of ProMed, who will manufacture SX600 in the same cleanroom in which we previously developed the technology and manufactured clinical batches.

Summit Health Names Timothy Reish, M.D., Chair of Orthopedics and Sports Medicine, Pain Management and Podiatry

Retrieved on: 
Tuesday, April 2, 2024
Health, Surgery, Practice Management, Physical Therapy, Other Health, Managed Care, General Health, Knee, Shoulder, Orthopedic surgery, Patient, Franklin Avenue, Research, Pain management, Elbow, Summit Health, Summit, Sports medicine, Dentistry

Timothy Reish, M.D., has been named Chair of Orthopedics and Sports Medicine, Pain Management and Podiatry of Summit Health’s NY South region.

Key Points: 
  • Timothy Reish, M.D., has been named Chair of Orthopedics and Sports Medicine, Pain Management and Podiatry of Summit Health’s NY South region.
  • He has been a practicing Orthopedic Surgeon in New York City for more than 20 years.
  • “We are thrilled that Dr. Reish will be leading three of our key departments that are essential to the health and well-being of our patients throughout their lifetime,” said Christine Masterson, M.D., executive vice president at Summit Health.
  • “I look forward to helping our Orthopedics, and Sports Medicine, Pain Management and Podiatry departments stay at the forefront of healthcare by offering the latest advancements and cutting-edge techniques in the fields of Orthopedics and Sports Medicine, Pain Management and Podiatry,” said Dr. Reish.

Miach Orthopaedics Raises $20 Million in Series B Extension

Retrieved on: 
Tuesday, April 2, 2024
Health, Surgery, Health Technology, Physical Therapy, Other Health, General Health, Biotechnology, Knee, Tears, Growth, Orthopedic surgery, 2018 Chinese Super League, Skiing, Artem, Patient, ACL, Anterior cruciate ligament, Athlete, NFLPA, Football, Innovation system, Basketball, MLSPA, NFL, Dentistry

Miach Orthopaedics, Inc. , a company transforming the treatment of anterior cruciate ligament (ACL) tears from reconstruction to restoration with the Bridge-Enhanced ACL Restoration (BEAR®) Implant, today announced closing of a $20 million Series B extension financing round.

Key Points: 
  • Miach Orthopaedics, Inc. , a company transforming the treatment of anterior cruciate ligament (ACL) tears from reconstruction to restoration with the Bridge-Enhanced ACL Restoration (BEAR®) Implant, today announced closing of a $20 million Series B extension financing round.
  • The BEAR Implant is the first disruptive technology in ACL tear treatment in more than 30 years.
  • It is a paradigm shift from the current standard of care – reconstruction that replaces the ACL with a graft.
  • “This Series B extension diversifies Miach’s investor group and provides additional resources to further market growth in the U.S. toward the goal of establishing the BEAR Implant as a new standard of care for ACL tears.”
    For more information about the BEAR Implant, visit miachortho.com .

Henry Schein Completes Acquisition of Majority Interest of TriMed, Inc.

Retrieved on: 
Thursday, April 4, 2024
Medical Devices, Health, Dental, Physical Therapy, Managed Care, Partnership, Patient, Foot, Sale, Acquisition, Ankle, MD, ASC, Extremities, Internationalized domain name, Wrist, Outpatient surgery

Henry Schein announced the agreement to acquire a majority interest of TriMed on December 20, 2023.

Key Points: 
  • Henry Schein announced the agreement to acquire a majority interest of TriMed on December 20, 2023.
  • The addition of TriMed will strengthen Henry Schein’s deep and longstanding relationship with existing Integrated Delivery Networks (IDNs) and Ambulatory Surgery Center (ASC) customers by providing a wider range of surgical solutions.
  • This reflects the Company’s strategy to expand the sale of Henry Schein-owned brands to new and existing customers.
  • Henry Schein expects the transaction to be neutral to 2024 non-GAAP earnings per share and accretive thereafter.

Garnett Station Partners Launches Accident Care Alliance, a Specialized Accident Injury Healthcare Services Platform

Retrieved on: 
Tuesday, April 2, 2024
Automotive, Physical Therapy, Professional Services, Managed Care, Other Health, Health, General Health, Neurology, Other Automotive, Asset Management, Telemedicine, Virtual Medicine, Pain management, Chiropractic, Patient, Garnett station, Accident, TBI, ACA, Elective surgery, Health insurance

Garnett Station Partners (“Garnett Station”), a New York-based principal investment firm that manages over $2.3 billion of assets, today announced the launch of Accident Care Alliance (“ACA”), a highly specialized platform comprised of best-in-class healthcare providers focused on delivering holistic, individualized care for those injured primarily in automobile accidents.

Key Points: 
  • Garnett Station Partners (“Garnett Station”), a New York-based principal investment firm that manages over $2.3 billion of assets, today announced the launch of Accident Care Alliance (“ACA”), a highly specialized platform comprised of best-in-class healthcare providers focused on delivering holistic, individualized care for those injured primarily in automobile accidents.
  • ACA partners with and grows industry-leading healthcare providers that support an underserved population of individuals injured in automobile accidents and are in need of adequate access to timely, premium healthcare services.
  • “We are building ACA around delivering convenient access and exceptional services to patients who lack access to best-in-class treatment options.
  • Rafi Haramati, Principal at Garnett Station, added, “The accident injury healthcare market is highly fragmented and growing, and with over half of accident injury cases in the United States resulting from automobile accidents, we see a great opportunity to build the leading platform to help improve the services available to injured patients.

Acadia Healthcare Accelerates Access to Care With Uber Health

Retrieved on: 
Tuesday, April 2, 2024
Physical Therapy, Mental Health, Technology, Managed Care, Law Enforcement, Emergency Services, General Health, Public Policy, Government, Infectious Diseases, Hospitals, Delivery Services, Other Transport, Health, Health Technology, Transport, Apps, Applications, Retail, Other Health, Comprehensive, Opioid, Patient, MAT, Chinese, Addiction, Acadia Healthcare, Senior counsel, CTC, Nursing

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced a collaboration with Uber Health (NYSE:UBER).

Key Points: 
  • Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced a collaboration with Uber Health (NYSE:UBER).
  • The two companies are coming together to improve access to life-saving behavioral health care and addiction treatment by providing patients access to transportation, so they can begin treatment quickly and efficiently.
  • “By joining forces with Uber Health, Acadia Healthcare can quickly and easily connect patients with transportation to get the care they need, when they need it—and ultimately help improve patient outcomes at scale.”
    At many of its CTC facilities, Acadia has used Uber Health for the past few years to provide transportation for patients.
  • The Uber Health platform allows Acadia to deliver care early in the patient’s recovery cycle.